Article Sidebar

Download
View Article
Statistic
Read Counter : 12 Download : 25

Main Article Content

Abstract

Candida albicans is the opportunistic mucosal infection that causes vulvovaginal candidiasis, which affects a lot of otherwise healthy women who are of childbearing age. So, the current study aimed to isolate and diagnose C. albicans from women with Vulvovaginal candidiasis and estimate the levels of some cytokines. Vaginal and blood samples were collected from women attending Salah al-Din Teaching Hospital, Department of Obstetrics and Gynecology - Consultation Clinic, and two groups of women were selected. The first group includes 200 women suffering from infections and their ages range from 18-59 years, and a second group of healthy women (40 women) whose ages range from 17-50 years for the period from November 2023 to May 2024. 200 samples were directly inspected under a microscope; of these, 58(29.0%) were found to be positive and 142(71.0%) to be negative. On the other hand, the Human C. albicans ELISA Kit was used for the purpose of detecting positive cases and their percentage. The results found that out of 200 women suffering from vaginitis, it was found that 27.5% were positive on the test, while the negative percentage of the test was 72.5%. for cytokines, IL-10 levels in serum of patients (37.15± 5.04) demonstrated significant (P <0.05) increase in compared with healthy subjects (14.94± 1.78). the levels of IFN-γ demonstrated significant (P <0.05) increase in patients (158.74 ± 12.55) compared with healthy subjects (39.13 ± 4.25). It is concluded that using the ELISA method is the best compared to traditional methods for diagnosing C. albicans, and vulvovaginal candidiasis led to an increase in the secretion of both IL-10 and IFN-γ for the purpose of raising the immune response

Keywords

Vulvovaginal candidiasis cytokines INF IL

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Hussein, A. S., & Ahmad, G. A. (2024). ISOLATE AND DIAGNOSE CANDIDA ALBICANS FROM WOMEN WITH VULVOVAGINAL CANDIDIASIS AND ESTIMATE THE LEVELS OF SOME CYTOKINES. Journal of Medical Genetics and Clinical Biology, 1(8), 262–268. https://doi.org/10.61796/jmgcb.v1i8.855
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. . J. M. Achkar and B. C. Fries, “Candida Infections of the Genitourinary Tract,” Clin. Microbiol. Rev., vol. 23, no. 2, pp. 253-273, Apr. 2010.
  2. . M. A. Farhan, A. M. Moharram, T. Salah, and O. M. Shaaban, “Types of Yeasts That Cause Vulvovaginal Candidiasis in Chronic Users of Corticosteroids,” Med. Mycol., vol. 57, no. 6, pp. 681-687, Aug. 2019.
  3. . H. A. R. Abbood and A. H. Saleh, “The Potential Role of Alkaloid Extract Against Phospholipase Extracted from Aspergillus flavus in Male Rats,” J. Global Pharma Technol., vol. 11, no. 7, pp. 548-551, 2019.
  4. . H. I. Abdullah, Y. H. Sawas, A. S. Anmar, and I. D. Batol, “Investigation of Genetic Diversity and Relationships Among the Clinical Candida Species Using Random Amplified Polymorphic DNA (RAPD) Analysis,” Res. J. Biotech., vol. 14, no. 1, pp. 6-13, 2019.
  5. . T. G. Bauters, M. A. Dhont, M. I. Temmerman, and H. J. Nelis, “Prevalence of Vulvovaginal Candidiasis and Susceptibility to Fluconazole in Women,” Am. J. Obstet. Gynecol., vol. 187, pp. 569-574, 2002.
  6. . J. D. Sobel, “Recurrent Vulvovaginal Candidiasis,” Am. J. Obstet. Gynecol., vol. 214, pp. 15-21, 2016.
  7. . B. Gonçalves, C. Ferreira, C. T. Alves, M. Henriques, J. Azeredo, and S. Silva, “Vulvovaginal Candidiasis: Epidemiology, Microbiology and Risk Factors,” Crit. Rev. Microbiol., vol. 42, pp. 905-927, 2016.
  8. . R. A. Hester and S. B. Kennedy, “Candida Infection as a Risk Factor for HIV Transmission,” J. Womens Health (Larchmt), vol. 12, pp. 487-494, 2003.
  9. . L. Masson et al., “Defining Genital Tract Cytokine Signatures of Sexually Transmitted Infections and Bacterial Vaginosis in Women at High Risk of HIV Infection: A Cross-Sectional Study,” Sex. Transm. Infect., vol. 90, pp. 580-588, 2014.
  10. . B. G. Mengesha and H. R. Conti, “The Role of IL-17 in Protection Against Mucosal Candida Infections,” J. Fungi (Basel), vol. 3, no. 1, pp. 52, 2017.
  11. . Y.-M. Jin et al., “Impaired Th17 Cell Proliferation and Decreased Pro-Inflammatory Cytokine Production in CXCR3/CXCR4 Double-Deficient Mice of Vulvovaginal Candidiasis,” J. Cell Physiol., vol. 234, pp. 13894-13905, 2019.
  12. . W. Jin and C. Dong, “IL-17 Cytokines in Immunity and Inflammation,” Emerg. Microbes Infect., vol. 2, no. 1, p. e60, 2013.
  13. . H. L. Lee et al., “Inflammatory Cytokines and Change of Th1/Th2 Balance as Prognostic Indicators for Hepatocellular Carcinoma in Patients Treated with Transarterial Chemoembolization,” Sci. Rep., vol. 9, p. 3260, 2019.
  14. . Y. Alvarez et al., “Preferential HIV Infection of CCR6+ Th17 Cells Is Associated with Higher Levels of Virus Receptor Expression and Lack of CCR5 Ligands,” J. Virol., vol. 87, pp. 10843-10854, 2013.
  15. . H. Sun et al., “Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence During Antiretroviral Therapy,” J. Virol., vol. 89, pp. 11284-11293, 2015.
  16. . L. Masson et al., “Genital Inflammation and the Risk of HIV Acquisition in Women,” Clin. Infect. Dis., vol. 61, pp. 260-269, 2015.
  17. . C. Guthrie and G. R. Fink, Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, vol. 194, San Diego, CA: Academic Press, pp. 1-932, 1991.
  18. . L. A.-A.-S. Sadiq Laylani and A. H. Saleh, “Alcoholic Extract Effect of Withania somnifera Roots on Cholesterol Diet Induced Hyperlipidemia in Male Rabbits,” Iraqi J. Sci., vol. 59, no. 1B, pp. 267-270, 2018.
  19. . A. S. Saeed and A. A. M. Saadullah, “Isolation, Identification and Antifungal Susceptibility Testing of Candida Species from Dermatologic Specimens in Duhok Province,” Zanco J. Pure Appl. Sci., vol. 31, no. 4, pp. 1-8, 2019.
  20. . Z. A. Mohsin and W. S. Ali, “Antagonistic Activity of Bacteriocin-Producing Lactobacillus Against Candida spp.,” Iraqi J. Sci., vol. 7, pp. 2153-2162, 2021.
  21. . N. S. Hussain, I. I. Latif, and H. H. Obaid, “Antimicrobial Activity of Non-Bond Colicin on Candida albicans Biofilm,” Iraqi J. Sci., vol. 4, pp. 2831-2837, 2020.
  22. . K. Ozcan et al., “Performance of Chromogenic Candida Agar and CHROMagar Candida in Recovery and Presumptive Identification of Monofungal and Polyfungal Vaginal Isolates,” Med. Mycol., vol. 48, no. 1, pp. 29-34, 2010.
  23. . J. Ponton, M. D. Moragues, and G. Quindos, “Non-Culture Based Diagnostics,” in Candida and Candidiasis, R. A. Calderone, Ed. Washington, D.C.: American Society for Microbiology, pp. 395-425, 2002.
  24. . G. Quindos, M. D. Moragues, and J. Ponton, “Is There a Role for Antibody Testing in the Diagnosis of Invasive Candidiasis?,” Rev. Iberoam. Micol., vol. 21, pp. 10-14, 2004.
  25. . E. Roilides et al., “Suppressive Effects of Interleukin-10 on Human Mononuclear Phagocyte Function Against Candida albicans and Staphylococcus aureus,” J. Infect. Dis., vol. 178, no. 6, pp. 1734-1742, 1998.
  26. . N. Ahmadi, A. Ahmadi, and E. Kheirali, “Cytokines Dysregulation and Induction of Regulatory T Cells,” J. Med. Mycol., vol. 29, no. 1, pp. 49-55, 2018.
  27. . M. Schaller et al., “Polymorphonuclear Leukocytes (PMNs) Induce Protective Th1-Type Cytokine Epithelial Responses in an In Vitro Model of Oral Candidosis,” Microbiology (Reading), vol. 150, no. 9, pp. 2807-2813, 2004.
  28. . J. Y. Djeu, D. K. Blanchard, D. Halkias, and H. Friedman, “Growth Inhibition of Candida albicans by Human Polymorphonuclear Neutrophils: Activation by Interferon-Gamma and Tumor Necrosis Factor,” J. Immunol., vol. 137, pp. 2980-2984, 1986.
  29. . L. Marodi et al., “Enhancement of Macrophage Candidacidal Activity by Interferon-Gamma: Increased Phagocytosis, Killing, and Calcium Signal Mediated by a Decreased Number of Mannose Receptors,” J. Clin. Invest., vol. 91, pp. 2596-2601, 1993.
  30. . L. Marodi, “Deficient Interferon-Gamma Receptor-Mediated Signaling in Neonatal Macrophages,” Acta Paediatr. Suppl., vol. 91, pp. 117-119, 2002.